RecBio
company
About
Focusing on major innovative vaccines with independent intellectual property rights.
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥1.50B
- Industries
- Health Care,Life Science
- Founded date
- Jan 1, 2012
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥1.50B
RecBio has raised a total of
¥1.50B
in funding over 2 rounds. Their latest funding was raised on
Nov 11, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 11, 2020 | Series B | ¥1.50B | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
RecBio is funded by 2 investors.
HT Capital
and China Everbright Investment Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
HT Capital
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
